-
Supreme Court stays proceedings before Bombay High Court on plea related to COVID-19 vaccination
The Supreme Court stayed the proceedings before the Bombay High Court on the plea seeking COVID-19 vaccination on priority basis for members of the le
-
WHO rejects SII’s proposal seeking extension of Covishield’s shelf life from 6 to 9 months
The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date
-
Require around Rs 3,000 crore to ramp up vaccine production: SII CEO Adar Poonawalla
We need roughly Rs 3,000 crores which is not a small figure considering we have already spent thousands of crores, says Adar Poonawalla
-
Money9 Edit | Vaccine makers should get financial assistance
India is at an advantageous position as two companies are producing the vaccine and the government should extend all help to increase production
-
Adar Poonawalla says hopes to launch Covovax trials in India by September 2021
In August 2020, American vaccine company Novavax had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373
-
India’s daily COVID-19 cases cross 50,000 on lockdown anniversary
India's known coronavirus cases are approaching 12 million, with more than 160,000 deaths
-
India’s vaccine diplomacy places image over self-interest
The goodwill generated by vaccine diplomacy could dissipate if India’s domestic majoritarian push makes it a regional bully and also less of a democ
-
Serum Institute of India seeks Centre’s nod to supply 50 lakh Covishield doses to UK
Serum Institute of India assured the Centre that its own anti-coronavirus vaccination programme will not be disturbed because of this supply
-
Govt places new purchase order with SII for 10 crore doses of Covishield vaccine
The cost of the 10 crore doses of the Oxford-AstraZeneca COVID-19 vaccine, Covishield, would be borne by the health ministry under the budgetary alloc
-
US export curbs can limit COVID-19 vaccine production, availability: Adar Poonawalla
"If we are talking about building capacity all over the world, the sharing of these critical raw materials, which just can't be replaced in a matter o
